Clinical Trials

Study Title:
A Phase II Study of the Addition of Opaganib to Androgen Antagonists in Patients with Prostate Cancer Progression on Enzalutamide or Abiraterone

For more information about the trial above please contact the study team: Trial opened at the following institutions: Emory University